MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 93 positions · Total reported value $4.88B · Top-10 concentration 41.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, MONTANOVA CAPITAL, LLC disclosed 93 equity positions with a combined reported value of $4.88B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were SPY ($545.54M), ARQT ($347.43M), ARKG ($241.68M). By sector, the heaviest allocations are Health Care 44.4%, Technology 15.0%. Versus the prior quarter, allocation shifted toward Health Care (+4.2pp), Consumer Discretionary (+3.1pp) and away from Miscellaneous (-1.1pp), Consumer Staples (-1.2pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q4 2025 were ARKG ($241.68M), HIMS ($83.10M), SYY ($79.86M).

Of the 14 positions fully exited versus the prior quarter, the largest were ETNB ($121.72M), XBI ($50.10M), RNAM ($32.68M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • ARKG ARK ETF TR · $241.68M
  • HIMS HIMS & HERS HEALTH INC · $83.10M
  • SYY SYSCO CORP · $79.86M
  • CAPR CAPRICOR THERAPEUTICS INC COM NEW · $51.53M
  • MGM MGM RESORTS INTERNATIONAL · $43.86M
  • QURE UNIQURE NV · $29.12M
  • COHR COHERENT CORP · $25.46M
  • CMG CHIPOTLE MEXICAN GRILL INC · $25.39M

Fully Exited (vs previous quarter)

  • ETNB 89BIO INC · prev qtr: $121.72M
  • XBI SPDR SERIES TRUST · prev qtr: $50.10M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $32.68M
  • KDP KEURIG DR PEPPER INC · prev qtr: $25.51M
  • MRVL Marvell Technology Inc · prev qtr: $22.89M
  • SNOW SNOWFLAKE INC · prev qtr: $20.12M
  • MRK MERCK & CO. INC. · prev qtr: $18.40M
  • PINS PINTEREST INC · prev qtr: $15.99M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 44.4%
Technology 15.0%
Financials 4.6%
Other 21.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 800.00K $545.54M 11.18%
11.18%
Hold
2 11.96M $347.43M 7.12%
7.12%
Add
3 8.34M $241.68M 4.95%
4.95%
New
4 11.55M $155.56M 3.19%
3.19%
Add
5 6.61M $143.67M 2.94%
2.94%
Add
6 7.83M $143.01M 2.93%
2.93%
Add
7 5.19M $123.65M 2.53%
2.53%
Add
8 11.19M $117.50M 2.41%
2.41%
Reduce
9 10.29M $116.14M 2.38%
2.38%
Add
10 169.07K $111.60M 2.29%
2.29%
Reduce
11 4.14M $103.98M 2.13%
2.13%
Add
12 530.90K $99.01M 2.03%
2.03%
Add
13 1.38M $96.67M 1.98%
1.98%
Reduce
14 310.26K $95.57M 1.96%
1.96%
Hold
15 406.15K $93.75M 1.92%
1.92%
Add
16 892.40K $93.41M 1.91%
1.91%
Add
17 8.58M $89.10M 1.82%
1.82%
Add
18 1.52M $83.47M 1.71%
1.71%
Add
19 389.58K $83.43M 1.71%
1.71%
Reduce
20 2.56M $83.10M 1.70%
1.70%
New
21 240.86K $82.88M 1.70%
1.70%
Add
22 4.11M $82.61M 1.69%
1.69%
Add
23 271.40K $82.48M 1.69%
1.69%
Reduce
24 1.08M $79.86M 1.64%
1.64%
New
25 542.89K $78.59M 1.61%
1.61%
Add
26 159.69K $77.23M 1.58%
1.58%
Add
27 4.77M $77.01M 1.58%
1.58%
Hold
28 14.18M $76.16M 1.56%
1.56%
Add
29 6.56M $74.21M 1.52%
1.52%
Add
30 389.44K $59.66M 1.22%
1.22%
Add
31 244.30K $55.93M 1.15%
1.15%
Reduce
32 1.54M $55.84M 1.14%
1.14%
Reduce
33 14.50M $53.95M 1.10%
1.10%
Hold
34 199.90K $52.96M 1.08%
1.08%
Add
35 3.36M $52.68M 1.08%
1.08%
Hold
36 1.79M $51.53M 1.06%
1.06%
New
37 2.02M $46.44M 0.95%
0.95%
Hold
38 226.32K $44.11M 0.90%
0.90%
Hold
39 1.20M $43.86M 0.90%
0.90%
New
40 171.97K $41.68M 0.85%
0.85%
Reduce
41 91.25K $41.04M 0.84%
0.84%
Hold
42 8.67M $40.92M 0.84%
0.84%
Add
43 111.32K $36.75M 0.75%
0.75%
Add
44 159.19K $35.44M 0.73%
0.73%
Reduce
45 353.56K $33.71M 0.69%
0.69%
Hold
46 2.84M $32.48M 0.67%
0.67%
Add
47 5.57M $29.17M 0.60%
0.60%
Add
48 1.22M $29.12M 0.60%
0.60%
New
49 12.34M $27.64M 0.57%
0.57%
Hold
50 137.93K $25.46M 0.52%
0.52%
New

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, MONTANOVA CAPITAL, LLC reported 93 equity positions worth $4.88B in aggregate; its largest disclosed positions were SPY ($545.54M), ARQT ($347.43M), ARKG ($241.68M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $4.88B of long equity holdings across 93 positions as of 2025-Q4. Top-10 holdings account for 41.9% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →